ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 102 filers reported holding ORIC PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,040,748 | -21.5% | 1,163,760 | +0.7% | 0.00% | 0.0% |
Q2 2023 | $8,971,414 | +69306.0% | 1,156,110 | -49.0% | 0.00% | -42.9% |
Q1 2023 | $12,926 | +16.5% | 2,267,642 | +20.4% | 0.01% | +16.7% |
Q4 2022 | $11,097 | -99.8% | 1,883,978 | +23.2% | 0.01% | +100.0% |
Q3 2022 | $4,892,000 | -24.3% | 1,528,608 | +6.0% | 0.00% | -25.0% |
Q2 2022 | $6,460,000 | +220.4% | 1,441,977 | +282.0% | 0.00% | +300.0% |
Q1 2022 | $2,016,000 | -50.8% | 377,491 | +62.8% | 0.00% | -66.7% |
Q2 2021 | $4,101,000 | +35.6% | 231,853 | +87.8% | 0.00% | +50.0% |
Q1 2021 | $3,025,000 | -12.3% | 123,457 | +21.2% | 0.00% | 0.0% |
Q4 2020 | $3,448,000 | +463.4% | 101,862 | +315.9% | 0.00% | +100.0% |
Q3 2020 | $612,000 | – | 24,490 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Column Group LLC | 4,768,181 | $161,403,000 | 14.64% |
Invus Financial Advisors, LLC | 1,007,575 | $34,106,000 | 14.26% |
Euclidean Capital LLC | 1,400,435 | $47,405,000 | 10.04% |
Memorial Sloan Kettering Cancer Center | 602,272 | $20,387,000 | 8.63% |
EcoR1 Capital, LLC | 3,092,218 | $104,672,000 | 5.63% |
Ally Bridge Group (NY) LLC | 413,061 | $13,982,000 | 2.40% |
Asymmetry Capital Management, L.P. | 67,210 | $2,275,000 | 1.04% |
Orbimed Advisors | 2,921,967 | $98,909,000 | 0.86% |
Casdin Capital, LLC | 601,515 | $20,361,000 | 0.60% |
EMERALD ADVISERS, LLC | 522,302 | $17,680,000 | 0.59% |